Importantly, these findings reveal a dominant role for HSPA6 and HSPA5 in the CTCL adaptive response to ER stress-inducing drugs, leading us to hypothesize that these Hsp70 family members are attractive drug targets in CTCL. This evidence concerns the gene TSPYL2 and primary cutaneous T-cell non-Hodgkin lymphoma.